Arena Pharma (ARNA) – Hot FDA News
-
Arena Pharma (ARNA) Phase 2b CAPTIVATE Clinical Trial Did Not Meet Primary Efficacy Endpoint
-
Arena Pharma (ARNA) lower as FDA request withdraw of weigh-loss drug Belviq from market
-
-
-
-
-
-
-
-
-
-
-
-
Back to ARNA Stock Lookup